Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview

AVITA Medical

20/01/2023 21:38

* AVITA Medical Inc  RCEL.OQ   RCEL.O  is expected to show a
rise
in quarterly revenue when it reports  results on February 23. 
    * The Valencia California California-based  company is
expected to
report  a 25.1% increase in revenue to $8.675 million from $6.94
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AVITA Medical Inc
is for
a loss of 29 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AVITA
Medical Inc
is $16​, above​ its last closing price of $8.72. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.34       -0.34      -0.22     Beat    35.2
 Jun. 30 2022  -0.38       -0.39      -0.25     Beat    35.9
 Mar. 31 2022  -0.39       -0.38      -0.38     Met     0​
                                      -0.34             
 ​​                                                     
                                                        ​
 This summary was machine generated January 20 at 21:38 GMT.  All
figures in US dollars  unless otherwise stated